Eric Mishkin, Ph.D.

Vice President and Chief Scientific Officer

Eric joined VaxDesign as Vice President and Chief Scientific Officer in January 2006. Eric brings more than 20 years of experience in biomedical research and development in academic and industrial settings, with a primary focus in vaccine R&D. From July 2002 until December 2004, he served as Vice President and Chief Scientific Officer for Bioject Medical Technologies where he had responsibility for development of preclinical and clinical applications of needle-free delivery of vaccines and immunotherapeutics. From August 1999 through May 2002, he was Director of Immunology Research of Wyeth-Ayerst Research, where he led viral vaccine Discovery Research efforts. His additional healthcare experience includes Associate Director and Department Head of Viral Vaccine Immunology for Wyeth-Lederle Vaccines and Pediatrics from May 1995 through August 1999, Group Leader of Viral Vaccine Immunology Research for Lederle-Praxis Biologics from January 1992 through May 1995, and various research positions in the Department of Viral Vaccine Research and Development for Lederle-Praxis Biologicals from July 1987 through January 1992.